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Adipose tissue expansion involves the enlargement
of existing adipocytes, the formation of new cells
from committed preadipocytes, and the coordinated
development of the tissue vascular network. Here we
find that murine endothelial cells (ECs) of classic
white and brown fat depots share ultrastructural
characteristics with pericytes, which are pluripotent
and can potentially give rise to preadipocytes.
Lineage tracing experiments using the VE-cadherin
promoter reveal localization of reporter genes in
ECs and also in preadipocytes and adipocytes of
white and brown fat depots. Furthermore, capillary
sprouts from human adipose tissue, which have
predominantly EC characteristics, are found to
express Zfp423, a recently identified marker of prea-
dipocyte determination. In response to PPARg acti-
vation, endothelial characteristics of sprouting cells
are progressively lost, and cells form structurally
and biochemically defined adipocytes. Together
these data support an endothelial origin of murine
and human adipocytes, suggesting a model for how
adipogenesis and angiogenesis are coordinated
during adipose tissue expansion.
INTRODUCTION
The obesity epidemic associated with increased risk of
type 2 diabetes has underscored the need to understand the
relationship between excess caloric intake, white adipose
tissue (WAT) development, and metabolic disease. Mammals,
including humans, also have metabolically active brown adipose
tissue (BAT) (Cypess et al., 2009; van Marken Lichtenbelt et al.,
2009; Virtanen et al., 2009), and BAT precursors can be found
in adipose organ of adult humans (Zingaretti et al., 2009). BAT
has antiobesity properties; therefore, the mechanisms by which
brown adipocytes emerge under different physiological and
pharmacological conditions are under intensive investigation.
Adipose tissue growth is mediated by adipocyte hypertrophy,
but in obesity adipose tissue may reach 60%–70% of body222 Cell Metabolism 15, 222–229, February 8, 2012 ª2012 Elsevier Inweight, requiring hyperplasic growth (Prins and O’Rahilly,
1997; Hausman et al., 2001). Therefore, defining the identity of
adipocyte precursors is an area of intense interest. Markers of
precursor cells giving rise to committed preadipocytes are being
identified (Gupta et al., 2010), and a population of early adipocyte
progenitor cells expressing stem cell markers has been charac-
terized in mouse WAT (Rodeheffer et al., 2008). Furthermore,
PPARg lineage tracing studies indicate that the vascular wall of
adipose tissue capillaries represents the niche of adipocyte
precursors (Tang et al., 2008).
Adipose tissue growth requires concomitant expansion of its
capillary network (Hausman and Richardson, 2004; Christiaens
and Lijnen, 2010), but how adipocyte formation and capillary
expansion are coordinated is unclear. The stromal-vascular frac-
tion (SVF) cells of adipose tissue differentiate in vitro into either
an adipogenic or a perivascular phenotype (Cinti et al., 1984;
Gregoire, 2001), but the identity of these progenitor cells in vivo
is unknown (Gesta et al., 2007). Since cell morphological
features are closely related to their function, a careful ultrastruc-
tural analysis during development could provide information on
the origin and anatomical localization of adipose tissue
precursors.
VE-cadherin is required for the formation of vasculature and is
expressed specifically in endothelial cells (ECs) of fetal and adult
mice. VE-cadherin-Cre-dependent LacZ and eGFP reporter
strains show localization of the reporters in EC of many tissues
(Alva et al., 2006; Monvoisin et al., 2006; Zovein et al., 2008;
Speck and Iruela-Arispe, 2009). However, VE-cadherin is also
expressed in subpopulations of hematopoietic cells before
embryonic day 11.5 (E11.5), and thus their descendants are
potentially labeled into adulthood (Alva et al., 2006; Monvoisin
et al., 2006; Zovein et al., 2008). To circumvent this problem,
mice in which VE-cadherin-driven Cre is induced during adult-
hood have also been created, resulting in negligible excision
(lower than 0.4%) in the hematopoietic lineage (Monvoisin
et al., 2006). Lineage tracing with constitutive and inducible
VE-cadherin-driven Cre can provide information on the relation-
ship between vascular and adipose cell development by allowing
the identification of cells that express this EC gene at any point
during embryonic and postnatal periods.
An additional tool to define the relationships between newly
formed vasculature and the genesis of new adipocytes is the
use of mouse and human adipose tissue explants cultured
ex vivo (Greenway et al., 2007; Gealekman et al., 2011). In thisc.
Figure 1. Murine Embryonic and Postnatal eWAT Morphology
(A) eWAT depot at E18 composed of poorly differentiated mesenchymal cells (m, mitosis; some capillaries indicated with asterisk).
(B) eWAT at P7, where adipocytes appear yellowish in areas with abundant large capillaries (asterisks).
(C and D) EM micrograph of a vasculo-adipocytic islet showing EC (e, elongated cells), tight junctions (tj), pericytes (p, poorly differentiated cells with glycogen
granules and surrounded by a distinct basal membrane), preadipocytes (pa, cells with small lipid droplets [L]), and glycogen granules in pericyte (arrow).
(E) EC and pericytes of a capillary wall (asterisk indicates the capillary lumen).
(F) Enlargement of the black squared area in (E) revealing EC in endothelial-pericytic position.
(G) Enlargement of the red squared area in (E) highlighting typical oblique tight junction (arrow) joining cell in endothelial-pericytic position to adjacent EC.
(H) Example of cell in endothelial-pericytic position containing abundant glycogen (arrows).
(I) Example of a ‘‘pure’’ EC containing abundant glycogen (arrow).
(J) Example of a cell partially associated with the capillary wall (arrowheads) and partially abutting into the interstitial space.
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Origin of Adipocytes from Vascular Endotheliummanuscript, we have used these morphological, genetic, and
functional approaches and obtained evidence that ECs of capil-
laries in developingWAT and BAT depots can give rise to mature
adipocytes. Our findings will enable further studies of the
biochemical and physiological cues controlling adipose tissue
growth.
RESULTS AND DISCUSSION
Ultrastructural Identification of Endothelial-Pericytic
Cells as Possible Intermediate between EC and
Preadipocytes
Before birth, rat (Figure 1A) and mouse (not illustrated) epidid-
ymal fat (eWAT) show the typical features of a poorly differ-
entiated mesenchymal tissue, consisting of a homogeneous
population of fibroblast-like cells, often in mitosis (Figure 1A,
m), in a loose connective matrix with small and sparse capillaries
(Figure 1A, asterisks). In contrast, at postnatal day 6–8 (P6–8)
(Figure 1B), well-circumscribed areas with a majority of cells
identifiable as adipocytes due to the predominantly unilocularCell Mcytoplasmic lipid droplets (Figure 1B, yellowish color) are
observed. These areas are delimited by fibroblast-like cells
and contain numerous large capillaries (Figure 1B, asterisks).
These are about 3-fold larger than capillaries found in eWAT of
adult animals, suggesting they have functions additional to
oxygen and nutrient exchange. Adipogenesis appears to be
restricted into these vasculo-adipocytic islets. Electron micros-
copy of these islets reveals dense collagen fibrils in the interstitial
matrix and thick capillary walls due to the presence of abundant
pericytes (Figures 1C and 1D). Most of the cells located in the
peri-capillary position of the vasculo-adipocytic islets corre-
spond to the cells described above by EM and show nuclear
staining for transcription factors widely considered as markers
of adipogenic conversion, such as PPARg, C/EBPa, and
C/EBPb (Figures S1A–S1C). These results are consistent with
studies suggesting that pericytes are precursors of preadipo-
cytes (Iyama et al., 1979; Tang et al., 2008). Some ECs are
also positive for C/EBPb (Figure S1D, arrowhead), which is
located upstream of PPARg and C/EBPa in transcriptional
control of adipogenesis (Farmer, 2006).etabolism 15, 222–229, February 8, 2012 ª2012 Elsevier Inc. 223
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Origin of Adipocytes from Vascular EndotheliumIn about 1%–3% of vasculo-adipocytic islet capillaries, ECs
exhibited unusual features by being exposed to the capillary
lumen, but also extended over a vicinal EC to adopt a pericytic
position (Figures 1E–1G, endothelial-pericytic cells). Importantly,
the junction of these cells with adjacent EC was composed of
typical oblique tight junctions (Figure 1G, arrow), confirming
the endothelial nature of these cells. EC and pericytes were
sometimes joined by tight junctions between a protrusion of
the EC crossing the basal membrane and the complementary
indentation in the pericyte (Figure S1E). Some of the ECs and
endothelial-pericytic cells contain glycogen granules (Figures
1H–1J, arrows), a characteristic feature of adipocyte progenitors
(Tavassoli, 1976). Almost all pericytes (Figure 1D), some ECs
(Figure 1I, arrow), and cells that are partially associated with
the capillary wall and also abut into the interstitial space (Fig-
ure 1J) also contain glycogen particles. These data reveal
a complex relationship between cells in the vasculo-adipocytic
islets where extensive adipogenesis is ongoing and suggest
that endothelial-pericytic cells represent an intermediate
between endothelial and preadipocyte stages (drawing in
Figure S1F).
Lineage Tracing Studies Show an Endothelial Origin
of Adipocytes
Data shown above suggest that EC may be among the cells
that give rise to new adipocytes. To address this hypothesis,
we performed VE-cadherin promoter-driven lineage tracing
experiments. VE-cadherin was expressed only in ECs and not
in pericytes (red arrowhead) or adipocytes of subcutaneous
(scWAT) (Figure 2A) and eWAT (data not shown) of adult animals.
Similarly, prior to adipocyte development in fetal and early post-
natal eWAT (Figures 2B and 2C) and scWAT (data not shown) of
VE-cadherin-Cre/R26R-LacZ mice, only ECs were X-gal posi-
tive. In contrast, from P6–8 (Figures 2D and 2E) to adult (Fig-
ure S2A), adipocytes at different stages of lipid accumulation in
eWAT and scWAT were also X-gal positive, indicating that
VE-cadherin promoter was expressed at some point during
adipocyte development. Control animals were always X-gal
negative (Figure S2B). To verify that the reporter was localized
to the adipocyte cytoplasm, we used EM and observed a precise
localization of X-gal crystals in ECs, pericytes, adipocytes (Fig-
ure S2C), and preadipocytes (Figure S2D). Similar results were
found using eGFP as a reporter; in developing eWAT adipocytes
of VE-cadherin-Cre/R26R-eGFP mice, perilipin and eGFP colo-
calized in adipocytes (Figure 2F). Internal positive control
(vessels) and other eGFP-positive adipocytes are shown in Fig-
ure S2E. These results further support the hypothesis that adipo-
cytes can develop in vivo from cells of endothelial origin.
These data prompted us to investigate whether brown adipo-
cytes might also have an endothelial origin. Immunohistochem-
istry for VE-cadherin confirmed its presence in ECs and its
absence in BAT pericytes and adipocytes (not illustrated).
However, the interscapular region of E17-19 VE-cadherin-Cre/
R26R-LacZ mice showed strong X-gal staining in both ECs
and adipocytes (Figures 2G and 2H), while in the surrounding
muscles only ECs were stained (Figure 2G). The X-gal staining
colocalized with the classical brown adipocyte marker UCP-1
(compare Figures 2I and 2J). Moreover, in the developing inter-
scapular brown fat depot (Figures S3A–S3B), some ECs display224 Cell Metabolism 15, 222–229, February 8, 2012 ª2012 Elsevier Incharacteristic markers (Figures S3C–S3E) and structural
features (glycogen and mitochondria) of UCP-1-positive brown
adipocyte precursors (Figures S3F–S3I). Taken together, these
data strongly suggest that ECs of developing WAT and BAT
capillaries are a source of adipocyte precursors. This is consis-
tent with the finding by Gupta et al. (2012) that pericytes and
some ECs of mouse adipose tissue express GFP driven by the
promoter for Zfp423, which marks cells determined to form pre-
adipocytes (Gupta et al., 2010). Moreover, PPARg excision with
the use of the Tie-2 promoter-driven Cre-recombinase, which is
expressed in a mosaic pattern in capillary endothelium (Anghe-
lina et al., 2005), results in a decrease in adiposity and adipocyte
size in response to rosiglitazone treatment in a manner depen-
dent on endothelial, but not bone marrow, PPARg expression
(Kanda et al., 2009). These findings constitute further evidence
supporting the possibility that certain EC populations can give
rise to adipocytes.
A hematopoietic origin of adipocytes has been suggested
(Crossno et al., 2006; Koh et al., 2007; Tomiyama et al., 2008).
To exclude the possibility that X-gal-positive adipocytes origi-
nate from hematopoietic lineage, we complemented our studies
with a tamoxifen-inducible transgenic VE-cadherin-CreERT2
model in which cells derived from hematopoietic precursors
are not labeled (Monvoisin et al., 2006). VE-cadherin-CreERT2/
R26R-LacZ mice at 8 weeks of age were induced by tamoxifen
injection for 5 consecutive days. Three weeks later, X-gal stain-
ing was observed in capillaries of adipose tissue, but also in
numerous adipocytes distributed among the eWAT (Figures 2K
and 2N), inguinal (Figures 2L and 2O), and brown (Figures 2M
and 2P) depots. The number of X-gal-positive adipocytes was
lower, as compared to the results described above, possibly
due to a lower number of adipocytes being formed during this
postnatal expansion period, but still clearly significantly above
the background, observed in negative controls (Figures 2Q–
2S). PPARg agonists affect murine adipose tissue by increasing
multilocularization of existing adipocytes and by stimulating pre-
adipocyte differentiation into mature adipocytes (Koh et al.,
2009; Tang et al., 2011). Mice treated with rosiglitazone for
3 weeks following induction displayed numerous multilocular
adipocytes, many of which were X-gal positive (Figures S3J–
S3L). Thus, under both normal and stimulated adipogenesis,
adipocytes arise from VE-cadherin expressing progenitors that
are not of hematopoietic origin.
A vascular origin for white and brown adipocytes may seem to
be in contradiction with the work of Seale et al., in which
a common origin of BAT and skeletal muscle cells (Seale et al.,
2008) was proposed. In this work, the authors found expression
of YFP in skeletal muscle and BAT from Myf5-Cre/R26R3-YFP
mice, consistent with both these tissues being derived from a
myogenic, Myf5-expressing progenitor. Interestingly, De Angelis
et al. have shown the existence of progenitor cells from embry-
onic dorsal aorta that express both myogenic and endothelial
markers including Myf5 and VE-cadherin (De Angelis et al.,
1999). Thus, one explanation for our results and those of Seale
et al. is that BAT is derived from a population of VE-cadherin-
positive and Myf5-positive cells, while muscle can be derived
from only Myf5-positive cells. Alternatively, as the Myf5-Cre
mouse model labels multiple cell lineages from somite
origin (Jinno et al., 2010), somite-derived cell progenitors thatc.
Figure 2. VE-Cadherin Lineage Tracing in WAT and BAT
(A) Immunohistochemical analysis on scWAT from VE-cadherin-Cre/R26R mice showing the specific expression of VE-cadherin only in EC (brown). Note the
negative pericytes indicated by red arrowhead.
(B and C) In early neonatal eWAT, only vasculature is X-gal positive.
(D and E) scWAT (D) and eWAT (E) from P7 mice revealing X-gal staining (arrows) in developing and mature adipocytes.
(F) Confocal microscopy of eWAT from VE-cadherin-Cre/eGFPRmice showing a single optical plane of adipocytes (arrows), containing eGFP (green) and perilipin
(red). Some eGFP-negative/perilipin-positive adipocytes are also visible (L).
(G) X-gal-positive staining in developing BAT and in muscle capillaries.
(H) Enlargement of the squared area in (G).
(I and J) X-gal (I) and UCP-1 (J) colocalization to brown adipocytes (arrows).
(K–P) eWAT (K and N), scWAT (L and O), and BAT (M and P) adipose tissue from VE-cadherin-CreERT2/+/R26R/+ mice showing X-gal-positive staining in
adipocytes and ECs.
(Q–S) Adipose tissues from VE-cadherin-CreERT2//R26R/+control mice.
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Origin of Adipocytes from Vascular Endotheliumsubsequently express VE-cadherin could in theory give rise to
BAT. If the brown adipocyte and muscle cell fates were deter-
mined before the expression of VE-cadherin, lineage tracing
experiments using the VE-cadherin-Cre mouse models would
not label myocytes.
Human Adipose Tissue Endothelial Sprouts Give Rise
to Adipocytes
The finding that murine cells with endothelial characteristics can
give rise to adipocytes prompted us to investigate whether
human adipocytes share this origin. Fragments of human
adipose tissue give rise to capillary sprouts when embedded in
Matrigel and cultured in proangiogenic media (GealekmanCell Met al., 2011). Classical EC ultrastructural features, including tight
junctions, irregular nuclei, and pinocytic vesicles, were seen in
cells comprising these sprouts (Figures 3A–3D). In regions
more proximal to the tissue explant, capillary lumens could be
observed (Figures 3E–3G), indicating that angiogenic develop-
ment is recapitulated ex vivo. Upon exposure to the PPARg
agonist rosiglitazone, many cells within the emerging capillary
sprouts produced lipid droplets (Figures 3H–3J). These cells
displayed canonical ultrastructural features of white adipocytes,
including a large lipid droplet, displaced nucleus, small and elon-
gated mitochondria, and glycogen particles distributed in the
cytoplasm (Figure 3K). Interestingly, these adipocytes showed
tight junctions identical to those found in sprouting EC andetabolism 15, 222–229, February 8, 2012 ª2012 Elsevier Inc. 225
Figure 3. Effect of Rosiglitazone on Angiogenic Sprouts Originating from Human Adipose Tissue
(A) Capillary outgrown after 15 days of culture in the absence of rosiglitazone, indicating areas distal and proximal to the embedded explants.
(B) Enlargement of area distal to the explants.
(C) Electron microscopy of area similar to that shown in (B), where tight junctions can be seen to connect cells.
(D) Enlargement of tight junction found between two ECs.
(E) Enlargement of area proximal to the explant.
(F) Electron microscopy of area similar to that shown in (E), revealing lumenized capillaries formed by ECs joined by tight junctions.
(G) Enlargement of area shown in (F).
(H) Capillary outgrowth after 15 days in the presence of rosiglitazone.
(I) Enlargement of area distal to the explant, revealing lipid droplets in cells interspersed among the capillary sprouts.
(J) Area proximal to the explant containing cells harboring larger lipid droplets.
(K) Electron microscopy of lipid-laden cells revealing features of classical white adipocytes and of ECs, such as the tight junction in the squared area.
(L) Enlargement of area outlined in (K).
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Origin of Adipocytes from Vascular Endotheliumbetween EC and pericytes in vivo (Figure 3L, compare with Fig-
ure S1). These results suggest that the processes of capillary
expansion and adipocyte formation seen in explants ex vivo
reflect those occurring in the intact organism.
We then asked whether these morphologically defined
adipocytes express genes that confer adipocyte function.
Induction of mRNAs encoding for the proteins GLUT4, adipo-
nectin, and leptin and a >100-fold increase in the expression
of the mRNA encoding the protein perilipin were observed (Fig-
ure 4A, top row) in parallel with decreased expression of
mRNAs encoding EC proteins such as tight junction protein
(TJP-1), CD34, and KDR (Figure 4A, bottom row). In addition,
the transcription factor Zfp423, considered a marker of adipo-
cyte lineage predetermination (Gupta et al., 2010), was de-
tected and increased significantly in response to rosiglitazone226 Cell Metabolism 15, 222–229, February 8, 2012 ª2012 Elsevier In(Figure 4B). The presence of this predetermination marker
and the strong induction of genes that define adipocyte func-
tion is consistent with the possibility that cells with endothelial
characteristics can give rise to adipocytes in human adipose
tissue.
To further examine the relationship between endothelial and
adipocyte markers at a single-cell level, we performed immuno-
fluorescence analysis. In the absence of rosiglitazone, most cells
contained low or undetectable levels of perilipin (Figure 4C) and
high levels of von Willebrand Factor (vWF) (Figure 4D). In the
presence of rosiglitazone, a majority of cells became vWF nega-
tive (Figure 4F), but exhibited a typical morphological feature of
adipocytes, perilipin-coated lipid droplets (Figure 4E). Neverthe-
less, approximately 5% of cells containing perilipin-coated lipid
droplets also contained vWF (Figure 4G). Similar cells containingc.
Figure 4. Coexpression of Endothelial and Adipose Cell Genes in Human and Mouse Systems
(A) Relative levels of mRNAs encoding canonical adipocyte (top row) or EC (bottom row) proteins in capillary outgrowth from explants grown for 14 days in the
absence (R) or presence (+R) of rosiglitazone.
(B) Relative levels ofmRNA encoding the adipocyte predeterminationmarker Zfp423. Plotted are themeans and SEMof 6–8 independent experiments. Statistical
significance was assessed by nonpaired, two-tailed Student’s t test. *p < 0.05; **p < 0.001.
(C and D) In the absence of rosiglitazone cells growing from human adipose explants are mostly perilipin negative (green) and vWF positive (red).
(E–G) In the presence of rosiglitazone, perilipin coating around lipid droplets is present (E), with the majority of cells becoming vWF negative (F) and about 5% of
cells coexpressing perilipin (green) and vWF (red) (G).
(H and I) Cells growing from adipose explants that accumulate lipid droplets in the presence of rosiglitazone (I) are also adiponectin positive (H).
(J) FACS analysis scheme of cells from SVF of eWAT and BAT.
(K) Comparison of CD45CD29+CD24+Sca1+ population and CD45CD29+CD24+Sca1+CD144+ (ASCM+) population between depots.
(L) Gating strategy for experiments. Plotted in graphs (K) are the means and SEM of three or four independent experiments. Data were analyzed using two-tailed
Student’s t test. *p < 0.00005; **p < 0.005. Fluorescence-minus-one antibody controls are in Figure S4.
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Origin of Adipocytes from Vascular Endotheliumlipid droplets were also found to express adiponectin (Figures 4H
and 4I), another specific feature of mature adipocytes. These
results are consistent with the hypothesis that adipocytes arise
from ECs or precursors expressing EC features. In line with these
observations, recent findings indicate that ECs can be converted
into mesenchymal stem cells, which can differentiate into adipo-
cytes, chondrocytes, and osteoblasts (Medici et al., 2010).
Furthermore, others have found that adipocytes have the poten-
tial to rapidly acquire an endothelial phenotype in vitro (Planat-
Benard et al., 2004), raising the possibility that adipocytes and
EC are plastic enough to undergo interconversion to maintain
a homeostatic equilibrium during adipose tissue expansion and
reduction.
Expression of VE-Cadherin in Adipocyte Progenitors
Characterized by Stem Cell Markers
To further examine the possibility that adipocytes and ECs
derived from each other or share a common precursor, we asked
whether cells expressing adipocyte stem cell markers (Rode-
heffer et al., 2008) were also positive for VE-cadherin (CD144).
CD45 cells from the SVF were successively gated for the pres-Cell Mence of CD29, CD24, and Sca1 (Figure 4H). Approximately 5%
and 10% of the cells in the SVF of eWAT and BAT, respectively,
were CD45CD29+CDC24+, and this difference was statis-
tically significant (Figure 4I, upper panel). Approximately
17% and 52% of the CD45CD29+CDC24+Sca-1+ population
in eWAT and BAT, respectively, were also positive for VE-
cadherin (CD144) (Figure 4H), comprising 0.5% and 4% of the
cells in the SVF of eWAT and BAT, respectively (Figure 4I, lower
panel). The percentages of adipogenic stem cells expressing
VE-cadherin are in line with the amount of endothelial-pericytic
cells found in WAT by EM studies in vivo, and the much larger
proportion of VE-cadherin-positive cells in BAT is consistent
with its denser vascular network. These data support the hypoth-
esis of an endothelial origin of adipocyte populations in these
depots.
In summary, we present morphological and genetic evidence
that adipocytes in white and brown fat depots originate from
cells that display endothelial characteristics. Further research
to identify the physiological signals that determine adipocyte
and/or EC fates will lead to a better understanding of the
mechanisms responsible for coordinating the formation ofetabolism 15, 222–229, February 8, 2012 ª2012 Elsevier Inc. 227
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Male Sprague Dawley rats and B6 mice (Harlan, Udine, Italy) were studied at
different developmental stages. At least five animals per group were used for
morphological studies performed by light, confocal, and electron microscopy
and immunohistochemistry. Homozygous VE-cadherin (VE-cadherin-Cre-
recombinase) transgenic mice were crossed to homozygous ROSA26R
(R26R) reporter and ROSA-eGFPR lines (Jackson Laboratory, Bar Harbor,
ME; stock no. 6137, 3474, and 4077, respectively) to reveal the activity of the
Cre-recombinase by detection of LacZ and eGFP reporter genes. The
VE-cadherin-R26R and VE-cadherin-eGFPR mice were studied at develop-
mental stage E18 (±12 hr) and at P6-8. Heterozygous VE-cadherin tamox-
ifen-inducible Cre-recombinase transgenic mice (VE-cadherin-CreERT2)
were crossed to homozygous R26R reporter animals. VE-cad-CreERT2/R26R
mice (8 weeks old) were i.p. injected with tamoxifen (2 mg/day) for 5 consecu-
tive days (Monvoisin et al., 2006). After injections, mice were fed normal diet
with or without rosiglitazone (10mg/kg/day) for 3 weeks. Mice were then sacri-
ficed, and BAT and WAT from epididymal and inguinal depots were harvested
for X-gal staining. Animal care and handling were in accordance with Italian
Institutional Guidelines and the Animal Care and Use Committee at UMass
Medical School.
Light Microscopy and Immunohistochemistry
Mouse and rat embryos were collected after mother perfusion with 4% para-
formaldehyde in 0.1 M PB (pH 7.4) and fixed by overnight immersion in the
same solution. Each embryo was then dehydrated, paraffin embedded, and
oriented to be cross-sectioned through the interscapular region. Newborn
rats and mice were perfused intracardially using the same fixative; bilateral
testes with peri-epididymal fat were dissected and embedded in paraffin. Light
microscopy, immunohistochemistry, and confocal microscopy were per-
formed using standard methods described in the Supplemental Experimental
Procedures.
Electron Microscopy and Immunogold Staining
After perfusion, small fragments of iBAT of fetal and postnatal eWATwere fixed
in 2% glutaraldehyde/2% paraformaldehyde in 0.1 M PB (pH 7.4) for at least
4 hr, postfixed in a solution of 1% osmium-tetroxide and 1% potassium hex-
acyanoferrate (II), dehydrated in acetone, and finally epoxy-resin embedded.
For immunogold staining, iBAT fragments fixed in 4% paraformaldehyde
were embedded in LR White Resin (London Resin Company, Reading, UK).
Sectioning, mounting, and examination are further described in the Supple-
mental Experimental Procedures.
X-Gal Staining for b-Galactosidase Tissue Localization
Male E18-19 and P6-8 and adult VE-cadherin-Cre/R26Rmicewere fixed in 2%
paraformaldehyde, 0.25% glutaraldehyde in PBS (pH 7.3) for 1 hr and washed
in PBS. Thick (500 mm) cross-sections through the interscapular region of iBAT
and eWAT were stained for b-galactosidase with the chromogenic substrate
X-gal, sectioned, counterstained, and imaged as described in the Supple-
mental Experimental Procedures.
Human Adipose Tissue Explants
Human scWAT was obtained from discarded tissue of patients undergoing
panniculectromy at UMASS Memorial Hospital. Pieces of 1 mm3 were
prepared and embedded in Growth Factor ReducedMatrigel (BDBiosciences)
on 35 mm glass-bottom culture dishes (MatTek Corporation) as described
previously (Gealekman et al., 2011), in the absence or presence of 1 mM rosi-
glitazone maleate. After 14 days in culture, immunofluorescence was
performed as described previously (Gealekman et al., 2011). Primary anti-
bodies used are stated in the Supplemental Experimental Procedures. For
RT-qPCR, the adipose tissue fragment was mechanically excised; the endo-
thelial sprouts remaining in the Matrigel were isolated using Dispase II (Roche,
2.4 U/ml) and centrifuged, and RNA was extracted from the pellet using an228 Cell Metabolism 15, 222–229, February 8, 2012 ª2012 Elsevier InAmbion RNA extraction kit. Probes used are specified in the Supplemental
Experimental Procedures.
Fluorescence-Activated Cell Sorting
SVF from eWAT and interscapular BAT from 8-week-old mice were isolated as
described (Fitzgibbons et al., 2011) and stained with blue stain (Invitrogen) at
4C for 20 min. Cells were incubated with anti-mouse CD16/CD32 (BD Biosci-
ences) for 15 min and then with respective FACS antibody for 2 hr at room
temperature. Antibodies used are stated in the Supplemental Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/
j.cmet.2012.01.008.
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